Gabapentin description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

Gabapentin

REMEDYREPACK INC.


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

GABAPENTIN DESCRIPTION




Gabapentin



CLINICAL PHARMACOLOGY

Mechanism of Action





PHARMACOKINETICS AND DRUG METABOLISM





Special Populations:Patients With Renal Insufficiency
DOSAGE AND ADMINISTRATION, Table 6

DOSAGE AND ADMINISTRATION

DOSAGE AND ADMINISTRATION

PRECAUTIONS, Geriatric UseDOSAGE AND ADMINISTRATION


DOSAGE AND ADMINISTRATION



CLINICAL STUDIES

Postherpetic Neuralgia





Gabapentin


Gabapentin



Gabapentin











Gabapentin







INDICATIONS & USAGE

Postherpetic Neuralgia

Epilepsy


GABAPENTIN CONTRAINDICATIONS



WARNINGS


















PRECAUTIONS: Carcinogenesis, Mutagenesis, Impairment of Fertility





PRECAUTIONS

Information for Patients



Drug Interactions
PRECAUTIONS, Pregnancy

LABORATORY TESTS



DRUG INTERACTIONS










PRECAUTIONS





DRUG & OR LABORATORY TEST INTERACTIONS



CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY






PREGNANCY






NURSING MOTHERS



PEDIATRIC USE


CLINICAL PHARMACOLOGY, Clinical Studies

CLINICAL PHARMACOLOGY, Clinical Studies

GERIATRIC USE



CLINICAL PHARMACOLOGYADVERSE REACTIONSDOSAGE AND ADMINISTRATION

GABAPENTIN ADVERSE REACTIONS










WARNINGS, Neuropsychiatric Adverse Events





















































DRUG ABUSE AND DEPENDENCE



OVERDOSAGE





DOSAGE & ADMINISTRATION








CLINICAL PHARMACOLOGY, Pediatrics













HOW SUPPLIED

















STORAGE AND HANDLING



PACKAGE LABEL.PRINCIPAL DISPLAY PANEL SECTION














Gabapentin

Gabapentin

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL















Gabapentin

Gabapentin

Gabapentin CAPSULE

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:49349-417(NDC:53746-102)
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
GABAPENTIN GABAPENTIN 300 mg

Inactive Ingredients

Ingredient Name Strength
CROSCARMELLOSE SODIUM
MAGNESIUM STEARATE
AMMONIA
FERROSOFERRIC OXIDE
BUTYL ALCOHOL
ALCOHOL
ISOPROPYL ALCOHOL
POTASSIUM HYDROXIDE
propylene glycol
water
SHELLAC
GELATIN
FERRIC OXIDE YELLOW
titanium dioxide

Product Characteristics

Color Size Imprint Code Shape
yellow 19 mm IP102 CAPSULE

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:49349-417-02 30 in 1 BLISTER PACK
2 NDC:49349-417-20 100 in 1 CANISTER

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA078428 2011-07-25


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.